Fungicidal antibiotic producing Streptomyces sp. NCIMB 40212
AssigneeMinistero Dell `Universita` E Della Ricerca Scientifica E Tecnologica
InventorsRossella Bortolo, Dante Cidaria, Giorgio Cassani, Adriana Vallesi, Gianfranco Gugliemetti, Giorgio Borgonovi, Silvia Spera, Giorgio Pirali, Giovanni Confalonieri
Life of this patent
Estimating the term…
Abstract
The Antibiotic Complex AB-023 and its components: Antibiotic AB-023a and ibiotic AB-023b are disclosed, which are obtained by the controlled aerobic culture of Streptomyces sp. NCIMB 40212 in an aqueous nutrient culture substrate. Antibiotics AB-023 display a biological activity against pathogen fungi which attack agricultural crops and man.
Claims2
A biologically pure culture of a microorganism Streptomyces sp. NCIMB 40212 or a mutant thereof capable of producing the Antibiotic Complex AB-023 in isolatable amounts by controlled aerobic fermentation in an aqueous nutrient substrate comprising assimilable carbon and nitrogen sources and inorganic salts, said Antibiotic Complex AB-023 being a solid characterized by:
- (a) good solubility in dimethyl-sulfoxide, methanol, ethanol, methanol:water (1:1, volume/volume [v/v]) mixture and ethanol:water (1:1, v/v) mixture, insolubility in water, hydrocarbons, acetonitrile, methylene chloride, chloroform;
- (b) approximate elemental analysis, expressed as percent values:
- carbon:
- 64.06;
- hydrogen:
- 8.78;
- the product does not contain nitrogen, phosphorus and sulfur;
- (c) absorbance peaks within the ultra-violet range at 304.0 nm, 317.2 nm, 332.4 nm, 350.4 nm at a concentration of 0.022 mg/ml in ethanol:water (50:50 v/v);
- (d) absorption peaks within the infrared range (cm.sup.-1):
- 3402, 3014, 2970, 2936, 2879, 2041, 1725, 1636, 1457, 1379, 1311, 1266, 1175, 1109, 1072, 1008, 905, 847, 823, 745, 706, 583, 535, 515, 480;
- (e) N.M.R. spectrum of .sup.1 H showing the following main peaks:
- (ppm):
- 6.43-6.24 (m, 12H);
- 6.24-6.07 (m, 4H);
- 5.96 (m, 2H);
- 5.62 (m, 2H);
- 5.33 (bs, 1H);
- 5.19 (bs, 1H);
- 5.03 (bs, 1H);
- 4.96 (bs, 2H);
- 4.93 (bs, 1H) 4.86 (m, 4H);
- 4.70 (m, 2H);
- 4.42 (bs, 2H);
- 3.94-3.36 (m, 12H);
- 2.41 (m, 2H);
- 2.32 (m, 1H);
- 2.20 (m, 1H);
- 1.92-1.45 (m, 6H), 1.45-1.09 (m, 42H);
- 1.25 (d, 6H);
- 1.11 (d, 3H);
- 1.07 (d, 6H);
- 0.95 (d, 6H), 0.88 (t, 3H);
- (f) N.M.R. spectrum of 1.degree. C. showing the following main peaks:
- (ppm):
- 173.7 (s);
- 173.1 (s);
- 136.5 (d);
- 136.5 (d);
- 136.5 (d);
- 136.3 (d);
- 133.1 (d);
- 133.1 (d);
- 132.9 (d);
- 132.9 (d);
- 132.7 (d);
- 132.5 (d);
- 132.1 (d);
- 131.9 (d);
- 131.6 (d);
- 131.4 (d);
- 131.2 (d);
- 131.1 (d);
- 130.6 (d);
- 130.3 (d);
- 129.5 (d);
- 129.2 (d);
- 74.7 (d);
- 74.4 (d);
- 74.1 (d);
- 73.6 (d);
- 72.0 (d);
- 71.9 (d);
- 71.5 (d);
- 71.4 (d);
- 71.4 (d);
- 71.2 (d);
- 69.7 (d);
- 69.6 (d);
- 67.7 (d);
- 67.3 (d);
- 54.1 (d);
- 46.1 (d);
- 45.5 (d);
- 45.4 (d);
- 43.4 (t);
- 42.9 (t);
- 41.7 (t);
- 41.5 (t);
- 40.1 (d);
- 39.5 (d);
- 38.9 (t);
- 38.9 (t);
- 38.8 (t);
- 38.7 (t);
- 38.2 (t);
- 38.1 (t);
- 22.5 (t);
- 22.4 (t);
- 22.1 (t);
- 19.0 (q);
- 18.7 (q);
- 15.9 (q);
- 15.6 (q);
- 13.2 (q);
- 11.3 (q);
- 10.4 (q);
- 10.2 (q);
- (g) a retention time (R.sub.t) of 3.65 minutes by reverse-phase HPLC on a Merck's Lichrosorb RP-18 column of mm 250.times.4, precolumn Merck C18, eluent MeOH:H.sub.2 O (86:14 v/v), with a flowrate of 1 ml/minute and at the temperature of 35.degree. C.
Dependencies are inferred from the claim text.